Veradermics (MANE) revenue

There is no revenue history on record here for Veradermics (MANE). Figures as of 18 Nov 2026, 11:27 UTC, from Yahoo Finance.

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of revenue needs at least 3 fiscal years; none is on record here for Veradermics. Nothing is estimated to fill the gap.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Veradermics and comparable companies
CompanyRevenueFiscal year
Scholar Rock Holding SRRK$33.19M2022
Teleflex TFX$1.99B2025
Mirum Pharmaceuticals MIRM$521.31M2025
Grifols GRFS€7.52B2025
Cogent Biosciences COGT$7.87M2020

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MANE

Veradermics, figure by figure

Veradermics (MANE) overview: price, valuation and scorecardAll health care companies by market value

Veradermics revenue: questions and answers

How is Veradermics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Veradermics (MANE) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/MANE/revenue

Underlying data: Yahoo Finance.